Kevin McKenzie
Presidente presso Alpex Pharma SA
Patrimonio netto: 100 500 $ in data 30/06/2024
Profilo
Kevin McKenzie currently works at Eureka Acquisition Corp., as Independent Director from 2024 and Alpex Pharma SA, as President.
Mr. McKenzie received his graduate degree from the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
0.70% | 01/07/2024 | 10 000 ( 0.70% ) | 100 500 $ | 30/06/2024 |
Posizioni attive di Kevin McKenzie
| Società | Posizione | Inizio |
|---|---|---|
Alpex Pharma SA
 Alpex Pharma SA Pharmaceuticals: MajorHealth Technology Alpex Pharma SA develops and produces orally dispersible tablet (ODT). Its products include Alpexicam and Meloxicam ODT. The firm also provides formulation development and contract manufacturing services. The company was founded in 1985 and is headquartered in Mezzovico, Switzerland. | Presidente | - |
Formazione di Kevin McKenzie
| University of Pennsylvania | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Alpex Pharma SA
Alpex Pharma SA Pharmaceuticals: MajorHealth Technology Alpex Pharma SA develops and produces orally dispersible tablet (ODT). Its products include Alpexicam and Meloxicam ODT. The firm also provides formulation development and contract manufacturing services. The company was founded in 1985 and is headquartered in Mezzovico, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Kevin McKenzie
